AVLSA

Atlas Venture Life Science Advisors Portfolio holdings

AUM $662M
This Quarter Return
+0.25%
1 Year Return
+6.63%
3 Year Return
+286.7%
5 Year Return
–
10 Year Return
–
AUM
$598M
AUM Growth
+$598M
Cap. Flow
+$5.05M
Cap. Flow %
0.84%
Top 10 Hldgs %
96.33%
Holding
17
New
–
Increased
1
Reduced
1
Closed
1

Top Buys

1
DAWN icon
Day One Biopharmaceuticals
DAWN
$13.7M

Top Sells

1
JBIO
Jade Biosciences, Inc. Common Stock
JBIO
$7.28M
2
COGT icon
Cogent Biosciences
COGT
$1.4M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
DAWN icon
1
Day One Biopharmaceuticals
DAWN
$769M
$161M 26.84%
8,968,305
+766,667
+9% +$13.7M
KYMR icon
2
Kymera Therapeutics
KYMR
$2.95B
$135M 22.63%
6,875,698
– –
DYN icon
3
Dyne Therapeutics
DYN
$1.92B
$61.4M 10.26%
8,934,902
– –
REPL icon
4
Replimune Group
REPL
$422M
$56.1M 9.38%
3,209,627
– –
GBIO icon
5
Generation Bio
GBIO
$40.4M
$54.3M 9.08%
8,278,876
– –
JBIO
6
Jade Biosciences, Inc. Common Stock
JBIO
$258M
$41.2M 6.89%
2,638,297
-465,582
-15% -$7.28M
IMA
7
ImageneBio, Inc. Common Stock
IMA
$150M
$22.2M 3.72%
5,018,178
– –
AKRO icon
8
Akero Therapeutics
AKRO
$3.74B
$21.1M 3.53%
2,232,251
– –
VIGL
9
DELISTED
Vigil Neuroscience
VIGL
$15.1M 2.52%
5,836,874
– –
IRON icon
10
Disc Medicine
IRON
$2.07B
$8.88M 1.48%
5,254,365
– –
XLO icon
11
Xilio Therapeutics
XLO
$36.3M
$8.06M 1.35%
2,759,344
– –
DNTH icon
12
Dianthus Therapeutics
DNTH
$759M
$4.17M 0.7%
3,476,536
– –
TECX
13
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$4.16M 0.7%
4,520,863
– –
FSTX
14
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$3.75M 0.63%
599,524
– –
VRDN icon
15
Viridian Therapeutics
VRDN
$1.5B
$1.04M 0.17%
90,072
– –
SPRO icon
16
Spero Therapeutics
SPRO
$116M
$764K 0.13%
1,031,160
– –
COGT icon
17
Cogent Biosciences
COGT
$1.69B
– –
-186,487
Closed -$1.4M